The dual role of STAT5—facilitating viral replication while promoting reservoir expansion—is exemplified by the study of De Armas et al., who demonstrated that the JAK1/2 inhibitors ruxolitinib and baricitinib significantly curtailed both latent and productive infection when administered 24 h post-infection in tonsillar CD4+ T cells. The gene discussed is CD4; the disease is infection.